Humana

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Humana 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About HUM

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. 

CEO
James A. Rechtin
CEOJames A. Rechtin
Employees
67,060
Employees67,060
Headquarters
Louisville, Kentucky
HeadquartersLouisville, Kentucky
Founded
1961
Founded1961
Employees
67,060
Employees67,060

HUM Key Statistics

Market cap
36.65B
Market cap36.65B
Price-Earnings ratio
32.65
Price-Earnings ratio32.65
Dividend yield
1.16%
Dividend yield1.16%
Average volume
2.06M
Average volume2.06M
High today
$310.94
High today$310.94
Low today
$295.00
Low today$295.00
Open price
$299.72
Open price$299.72
Volume
1.86M
Volume1.86M
52 Week high
$315.35
52 Week high$315.35
52 Week low
$163.11
52 Week low$163.11

Stock Snapshot

The current Humana(HUM) stock price is $297.00, with a market capitalization of 36.65B. The stock trades at a price-to-earnings (P/E) ratio of 32.65 and offers a dividend yield of 1.2%.

During the trading session on 2026-05-16, Humana(HUM) shares reached a daily high of $310.94 and a low of $295.00. At a current price of $297.00, the stock is +0.7% higher than the low and still -4.5% under the high.

Trading activity shows a volume of 1.86M, compared to an average daily volume of 2.06M.

The stock's 52-week range extends from a low of $163.11 to a high of $315.35.

The stock's 52-week range extends from a low of $163.11 to a high of $315.35.

HUM News

Simply Wall St 15h
Humana Valuation Check After Barostim Coverage Decision And Earnings Beat

Humana (HUM) has drawn fresh attention after issuing a Medicare Advantage coverage policy for Barostim therapy, widening access to heart failure treatment, whil...

Humana Valuation Check After Barostim Coverage Decision And Earnings Beat
TipRanks 1d
Humana price target raised to $217 from $146 at Morgan Stanley

Morgan Stanley analyst Erin Wright raised the firm’s price target on Humana (HUM) to $217 from $146 and keeps an Underweight rating on the shares. Shares are up...

24/7 Wall St. 3d
Piper Sandler Just Hiked Humana Price Target to $254: Medicare Advantage Beat Powers the Bull Case

Piper Sandler Just Hiked Humana Price Target to $254: Medicare Advantage Beat Powers the Bull Case By David Moadel Published May 13, 11:06AM EDT Quick Read Hu...

Piper Sandler Just Hiked Humana Price Target to $254: Medicare Advantage Beat Powers the Bull Case

Analyst ratings

69%

of 29 ratings
Buy
24.1%
Hold
69%
Sell
6.9%

More HUM News

Simply Wall St 4d
Humana Is Up 23.3% After Guiding Lower EPS Despite Strong Q1 Revenue Growth

In late April 2026, Humana Inc. reported first-quarter 2026 results showing revenue rising to US$39.65 billion from US$32.11 billion a year earlier, while net i...

Humana Is Up 23.3% After Guiding Lower EPS Despite Strong Q1 Revenue Growth
TipRanks 4d
Humana Announces Leadership Change in Personal Assistance Division

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

People also own

Based on the portfolios of people who own HUM. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.